This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Events & Webinars
  • Podcasts
  • Resources
  • Learning Zone
  • Products
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer cross colorful
Bayer for ProfessionalsYour Resource Portal
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Latest Highlights

    EYLEA® (aflibercept) 8 mg Pre-filled Syringe
    Access resources for the EYLEA® (aflibercept) 8 mg Pre-filled Syringe
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2676, January 2025

    Products

    EYLEA® (aflibercept) 2 mg
    Discover data and resources about EYLEA 2 mg
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2793, March 2025
    EYLEA® (aflibercept) 8 mg
    Discover data and resources about EYLEA 8 mg
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2911, July 2025

    HCP Resources

    Real World Experience
    Practical insights into the experiences of clinicians implementing treatment with EYLEA® (aflibercept) 8 mg in the UK
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2790, March 2025
    HCP Resources
    Access useful, downloadable ophthalmology resources for HCPs
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2866, June 2025
    Ophthalmology Patient Support Materials
    Access our range of downloadable patient support booklets and other resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2368, August 2024
    EYLEA® (aflibercept) Risk Minimisation Materials
    Visit to access Risk Minimisation Materials for EYLEA® (aflibercept)
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2647, December 2024

    Patient Support Materials

    Ophthalmology Patient Support Materials
    Access our range of downloadable patient support booklets and other resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2368, August 2024

    Learning Zone

    Bayer Ophthalmology Masterclass Programme
    Interactive meetings and a range of online resources to refresh your knowledge
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2702, January 2025
    Bitesize OCT Knowledge Checkers
    Test your knowledge of OCT disease biomarkers in this series of OCT images
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2892, August 2025

    Events & Webinars

    Effective Collaboration through Teamwork:
    How Bristol Eye Unit and BNSSG ICB developed a sustainable patient pathway for Medical Retina
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2410, August 2024
    Value-Based Prescribing:
    Enhancing NHS efficiency and sustainability in Ophthalmology Care
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2409, August 2024

    Retinal Pioneers Programme

    Retinal Pioneers Programme
    A source of on-demand, educational resources developed in collaboration with national and international thought leaders
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2908, August 2025

    Podcasts

    Bonus Episode
    with All Speakers
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2553, December 2024
    Drying Effects of EYLEA® (aflibercept) 8 mg
    with Hani Hasan, Rossella Anzidei and Richard Gale
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2552, December 2024
    The Importance of Clinical Audits
    with Hani Hasan
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2551, December 2024
    Practicalities of Using EYLEA® (aflibercept) 8 mg in Rout...
    with Bhavin Maru
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2550, January 2025